SAGE
Price:
$5.73
Market Cap:
$350.52M
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment resistant disorders, generalized anxiety disorders, and bipolar depression; and SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has completed Phase I clinical trial for epilepsy and Parkinson's diseases...[Read more]
Industry
Biotechnology
IPO Date
2014-07-18
Stock Exchange
NASDAQ
Ticker
SAGE
According to Sage Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Sage Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), SAGE's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Sage Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Sage Therapeutics, Inc. (SAGE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Sage Therapeutics, Inc.’s Dividend Yield is less than Apellis Pharmaceuticals, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Blueprint Medicines Corporation (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than Mirati Therapeutics, Inc. (0%), less than Amylyx Pharmaceuticals, Inc. (0%), less than Relay Therapeutics, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Pliant Therapeutics, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than Arvinas, Inc. (0%), less than Krystal Biotech, Inc. (0%), less than Alnylam Pharmaceuticals, Inc. (0%), less than Madrigal Pharmaceuticals, Inc. (0%), less than Incyte Corporation (0%), less than Reata Pharmaceuticals, Inc. (0%), less than DiaMedica Therapeutics Inc. (0%), less than Akero Therapeutics, Inc. (0%), less than Nuvalent, Inc. (0%), less than Immunocore Holdings plc (0%), less than Ventyx Biosciences, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $3.64B | |
0% | $605.41M | |
0% | $1.58B | |
0% | $6.14B | |
0% | $8.19B | |
0% | $4.12B | |
0% | $424.83M | |
0% | $994.26M | |
0% | $721.41M | |
0% | $841.00M | |
0% | $183.34M | |
0% | $1.81B | |
0% | $5.38B | |
0% | $34.69B | |
0% | $7.39B | |
0% | $15.52B | |
0% | $6.57B | |
0% | $184.24M | |
0% | $2.25B | |
0% | $6.35B | |
0% | $1.69B | |
0% | $148.41M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sage Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sage Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Sage Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Sage Therapeutics, Inc. (SAGE)?
What is the highest Dividend Yield for Sage Therapeutics, Inc. (SAGE)?
What is the 3-year average Dividend Yield for Sage Therapeutics, Inc. (SAGE)?
What is the 5-year average Dividend Yield for Sage Therapeutics, Inc. (SAGE)?
How does the current Dividend Yield for Sage Therapeutics, Inc. (SAGE) compare to its historical average?